Evidence map›Paper›PMID 23509685›Full record

ArticleBioMed research international2013

Antihyperglycemic effect of Ginkgo biloba extract in streptozotocin-induced diabetes in rats.

Daye Cheng, Bin Liang, Yunhui Li

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
12.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 171 citations in OpenAlex.

  1. The efficacy and safety ofDrug design, development and therapy · 2018
    Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Alleviate oxidative stress in diabetic retinopathy: antioxidant therapeutic strategies.Redox report : communications in free radical research · 2023
    Review
  11. Article
  12. Antioxidant Effect of the Ethyl Acetate Extract ofPlants (Basel, Switzerland) · 2023
    Article
  13. Diabetes mellitus: Preventive and curative therapies with aqueous extract ofJournal of traditional and complementary medicine · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Metabolites · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Daye ChengDepartment of Transfusion, The First Hospital of China Medical University, North Nanjing Street No. 155, Shenyang 110001, China. dayecheng_cmu@yahoo.cn
Bin Liang
Yunhui Li
China Medical University · CNFirst Hospital of China Medical University · CNShenyang 242 Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Ginkgo biloba extract (GBE) has been reported to have a wide range of health benefits in traditional Chinese medicine. The aim of this study was to evaluate the antihyperglycemic effects of GBE on streptozotocin- (STZ-) induced diabetes in rats. Diabetes was induced in male Wistar rats by the administration of STZ (60 mg/kg b.w.) intraperitoneally. GBE (100, 200, and 300 mg/kg b.w.) was administered orally once a day for a period of 30 days. Body weight and blood glucose levels were determined in different experimental days. Serum lipid profile and antioxidant enzymes in hepatic and pancreatic tissue were measured at the end of the experimental period. Significant decreases in body weight and antioxidant ability and increases in blood glucose, lipid profile, and lipid peroxidation were observed in STZ-induced diabetic rats. The administration of GBE and glibenclamide daily for 30 days in STZ-induced diabetic rats reversed the above parameters significantly. GBE possesses antihyperglycemic, antioxidant, and antihyperlipidemia activities in STZ-induced chronic diabetic rats, which promisingly support the use of GBE as a food supplement or an adjunct treatment for diabetics.

Indexed as

Administration, OralAnimalsAntioxidantsBlood GlucoseBody WeightDiabetes Mellitus, ExperimentalFree RadicalsGinkgo bilobaHypoglycemic AgentsLipid PeroxidationMaleOxidative StressPhytotherapyPlant ExtractsRatsRats, WistarAntioxidantsBlood GlucoseFree RadicalsHypoglycemic AgentsPlant Extracts

Identifiers

PMID23509685
PMCPMC3591163
OpenAlexW2057975302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.